Lipopolysaccharide (LPS) and related microbial Pathogen-Associated Molecular Patterns (PAMPs) (LPS/PAMPs)

Lipopolysaccharides (LPS) are complex glycolipids found in the outer membrane of Gram-negative bacteria that serve as potent initiators of the innate immune response (Beutler, B., 2004, Molecular Immunology). As the primary example of Pathogen-Associated Molecular Patterns (PAMPs), LPS is recognized by the host's Toll-like receptor 4 (TLR4) complex, triggering the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 (Park, B. S., & Lee, J. O., 2013, Experimental & Molecular Medicine). While this response is vital for pathogen clearance, excessive or systemic exposure to LPS can lead to clinical conditions such as sepsis, septic shock, and multi-organ failure (Opal, S. M., 2010, Contributions to Nephrology). Therapeutic strategies targeting LPS include the use of cationic antibiotics like polymyxins, which neutralize the lipid A component, and the development of TLR4 antagonists to prevent downstream signaling (Velkov, T., et al., 2013, Future Microbiology). Other microbial PAMPs, including peptidoglycans and flagellin, similarly interact with specific pattern recognition receptors to modulate immunity (Mogensen, T. H., 2009, Clinical Microbiology Reviews). Managing the balance between effective immune activation and harmful hyper-inflammation remains a significant challenge in treating PAMP-mediated diseases (Stearns-Kurosawa, D. J., et al., 2011, Annual Review of Pathology). Additionally, alkaline phosphatase enzymes are being explored for their ability to detoxify LPS by removing phosphate groups from its lipid A moiety (Peters, E., et al., 2015, Critical Care). The structural diversity of PAMPs across different microbial species influences the intensity and type of immune response elicited (Raetz, C. R., & Whitfield, C., 2002, Annual Review of Biochemistry).

Other names

EndotoxinMicrobial-associated molecular patternsMAMPsPyrogensLipoglycansLipid A

Direct neutralization of the lipid A moiety, competitive antagonism of the TLR4 receptor complex, and enzymatic detoxification via dephosphorylation.